Danaher Corporation

Integrated Stepper Motor Market size to increase by USD 53.22 million during 2023-2028, Need to ensure uninterrupted industrial operations to drive the growth - Technavio

Retrieved on:

Wednesday, November 1, 2023

NEW YORK, Nov. 1, 2023 /PRNewswire/ -- The integrated stepper motor market size is expected to grow by USD 53.22 million between 2023 and 2028.

Key Points:

NEW YORK, Nov. 1, 2023 /PRNewswire/ -- The integrated stepper motor market size is expected to grow by USD 53.22 million between 2023 and 2028.
The report analyses the market size and growth and provides accurate predictions on the growth of the market.
View a PDF Sample
The need to ensure uninterrupted industrial operations drives the integrated stepper motor market.
Explore detailed information by purchasing a report
Process industry segment to generate maximum revenue in the integrated stepper motor market and is the leading end-user segment in the global integrated stepper motor market.

Danaher appoints Christopher Riley to Executive Vice President for Biotechnology

Retrieved on:

Tuesday, October 31, 2023

Danaher, NYSE, Pall Corporation, Northwestern University, Boston, Genomic Medicine Institute, Danaher Corporation, Business administration, DHR, The Company, University, Mechanical, Boston Consulting Group, Patient, Champaign–Urbana metropolitan area, European Conservatives and Reformists Group Executive, Management

WASHINGTON, Oct. 31, 2023 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher" or the "Company"), a leading global life sciences and diagnostics innovator, today announced that Christopher Riley has been appointed by its Board of Directors to be Executive Vice President of Danaher with responsibility for its Biotechnology business, effective January 1, 2024.

Key Points:

WASHINGTON, Oct. 31, 2023 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher" or the "Company"), a leading global life sciences and diagnostics innovator, today announced that Christopher Riley has been appointed by its Board of Directors to be Executive Vice President of Danaher with responsibility for its Biotechnology business, effective January 1, 2024.
Mr. Riley, currently Vice President and Group Executive of Danaher's Life Sciences company with responsibility for Genomic Medicines, will become an executive officer of Danaher reporting to President and Chief Executive Officer, Rainer Blair.
His strong track record of delivering results, passion for helping our customers and building winning teams, plus his deep commitment to the Danaher Business System, is a tremendous asset for Danaher.
Previously he was Vice President and Group Executive for Danaher's Diagnostics company and, prior to that, held various roles of increasing responsibility across multiple Danaher subsidiaries.

Digital Asset Management Market to grow by USD 11.93 billion from 2022 to 2027, Market driven by the shift from on-premises to SaaS- Technavio

Retrieved on:

Tuesday, October 24, 2023

The potential growth difference for the digital asset management market between 2022 and 2027 is USD 11.93 billion.

Key Points:

The potential growth difference for the digital asset management market between 2022 and 2027 is USD 11.93 billion.
The shift from on-premises to SaaS is notably driving the digital asset management market growth.
Buy the full report here
Data privacy and security concerns are the major challenges impeding the digital asset management market growth.
The Enterprise Asset Management (EAM) Market size is estimated to grow at a CAGR of 7.85% between 2022 and 2027.

Apogee Enterprises Announces Leadership Transition

Retrieved on:

Wednesday, October 18, 2023

Apogee Enterprises, Inc. (Nasdaq: APOG) today announced a transition in its segment leadership.

Key Points:

Apogee Enterprises, Inc. (Nasdaq: APOG) today announced a transition in its segment leadership.
Brent will succeed Nick C. Longman, who has concurrently been named President of Apogee’s Architectural Framing Systems Segment.
“This transition will align Brent and Nick’s leadership strengths with the business needs of the two segments as we continue to advance our strategy.
Prior to Harvey, he held functional and businesses leadership roles at Colfax, Rexnord Corporation, and Danaher Corporation.

Integrated DNA Technologies Opens New Therapeutic Manufacturing Facility to Support Growing Demand in Genomic Medicine

Retrieved on:

Tuesday, October 17, 2023

Global genomics solutions provider Integrated DNA Technologies (IDT), an operating company in the Life Sciences segment of Danaher Corporation (NYSE:DHR), today announced the completion of its new Therapeutic Oligonucleotide Manufacturing facility in Coralville, Iowa.

Key Points:

Global genomics solutions provider Integrated DNA Technologies (IDT), an operating company in the Life Sciences segment of Danaher Corporation (NYSE:DHR), today announced the completion of its new Therapeutic Oligonucleotide Manufacturing facility in Coralville, Iowa.
These new capabilities and offerings will be supported with comprehensive documentation and testing, a support team, and regulatory guidance to help accelerate researchers’ path to the clinic.
As a pioneer in genome editing, IDT’s continued investments will enable customers to rapidly move from clinical development to commercialization.
Mortenson Company, a team led by OPN Architects and Barr Engineering Co. on the facility design and construction of its cGMP facility.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RPT, HT, ABCM, AGE

Retrieved on:

Sunday, October 8, 2023

Abcam, Danaher Corporation, NYSE, Kimco Realty, Fraud, AgeX Therapeutics, Advertising, Therapy, RPT, Sale, KSL Capital Partners, RPT Realty, Security (finance), Hersha Hospitality Trust

If you are a RPT shareholder, click here to learn more about your rights and options .

Key Points:

If you are a RPT shareholder, click here to learn more about your rights and options .
Hersha Hospitality Trust (NYSE: HT)’s sale to affiliates of KSL Capital Partners, LLC for $10.00 per share.
If you are a Hersha shareholder, click here to learn more about your rights and options .
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.

Independent Directors of Abcam Highlight Compelling Reasons for Shareholders to Support Proposed Sale to Danaher

Retrieved on:

Thursday, October 12, 2023

We are writing to you today as the independent non-executive directors of Abcam’s Board of directors to affirm that this agreement was the result of a rigorous, fair and competitive sale process.

Key Points:

We are writing to you today as the independent non-executive directors of Abcam’s Board of directors to affirm that this agreement was the result of a rigorous, fair and competitive sale process.
We unanimously support this Transaction as we believe it is the best deal available and is in the best interests of Abcam and its shareholders.
Ultimately, if this Transaction were not approved by shareholders, it is uncertain what path Abcam would be on next.
We need your support to secure a positive outcome for all Abcam shareholders.

ABCAM INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Abcam plc - ABCM

Retrieved on:

Tuesday, October 10, 2023

Class Action Lawsuit, Professional Services, Legal, DHR, Danaher Corporation, NYSE, KSF, Sale, Abcam

and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Abcam plc (NasdaqGS: ABCM) to Danaher Corporation (NYSE: DHR).

Key Points:

and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Abcam plc (NasdaqGS: ABCM) to Danaher Corporation (NYSE: DHR).
Under the terms of the proposed transaction, shareholders of Abcam will receive $24.00 in cash for each share of Abcam that they own.
KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com .

Molecular Devices Introduces CellXpress.ai Automated Cell Culture System, a 3D Biology Innovation Hub for Fast, Reliable Drug Discoveries

Retrieved on:

Monday, October 16, 2023

SAN JOSE, Calif., Oct. 16, 2023 /PRNewswire-PRWeb/ -- Molecular Devices, LLC., a leading high-performance life science solutions provider and an operating company in the life sciences segment of Danaher Corporation (NYSE:DHR), has launched the CellXpress.ai™ Automated Cell Culture System—an end-to-end, machine learning-enabled solution that automates demanding feeding and passaging schedules with an integrated incubator, liquid handler, and imager, giving scientists more time and autonomy in the lab. The visionary goal for this instrument is to reduce reliance on animal models in drug development while enhancing productivity, optimizing efficiency, and fast-tracking potential therapeutics to pre-clinical trials using human-relevant models earlier in the process.

Key Points:

"In drug discovery, we recognize the significance of having advanced cell culture protocols for 3D biology models," said Shantanu Dhamija, Vice President of Strategy and Innovation Molecular Devices.
Key features of the CellXpress.ai cell culture system include:
Reduce Labor Costs: Until now, large-scale cell culture has demanded round-the-clock oversight.
The CellXpress.ai cell culture system uses automation and AI to maintain this 24/7 schedule, improving workflows and making assays more reliable and reproducible.
To learn more or to join a community of researchers at the forefront of innovation using the CellXpress.ai cell culture system, visit CellXpressAI.com .

Cummins Elects Daniel W. Fisher to Its Board of Directors

Retrieved on:

Monday, October 9, 2023

Automotive Manufacturing, Manufacturing, Other Manufacturing, Machinery, Engineering, Multimedia, Danaher Corporation, NYSE, Fisher, Cummins, Ball Corporation, Emerson Electric, CMI, Software, Information technology, Management

Today, Cummins Inc. (NYSE: CMI) announced the election of Daniel W. Fisher to its Board of Directors.

Key Points:

Today, Cummins Inc. (NYSE: CMI) announced the election of Daniel W. Fisher to its Board of Directors.
View the full release here: https://www.businesswire.com/news/home/20231009108394/en/
“I am delighted to welcome Dan to our Board of Directors,” said Jennifer Rumsey, Chair and CEO, Cummins Inc. “Dan brings a wealth of financial, business operations, and leadership expertise to this role.
Prior to becoming CEO, Fisher served as President of the company, as well as many roles leading both Finance and Operations across several of Ball’s company divisions.
Prior to working at Ball Corporation, Fisher served as both a Director and Chief Financial and Information Technology Officer for Emerson Electric, a global technology, software and engineering company.